MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 196 filers reported holding MEDICINES CO in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,400,000 | +0.3% | 605,132 | -40.9% | 0.04% | -9.3% |
| Q3 2019 | $51,237,000 | +297.5% | 1,024,732 | +189.9% | 0.04% | +290.9% |
| Q2 2019 | $12,890,000 | +169.7% | 353,432 | +173.9% | 0.01% | +83.3% |
| Q3 2017 | $4,779,000 | -61.8% | 129,029 | -60.8% | 0.01% | -62.5% |
| Q2 2017 | $12,499,000 | +57.5% | 328,832 | +102.6% | 0.02% | +45.5% |
| Q1 2017 | $7,938,000 | -43.8% | 162,332 | -61.0% | 0.01% | -50.0% |
| Q4 2016 | $14,116,000 | +4513.1% | 415,900 | +5034.6% | 0.02% | +2100.0% |
| Q3 2016 | $306,000 | -96.6% | 8,100 | -97.2% | 0.00% | -94.1% |
| Q1 2016 | $9,129,000 | -1.8% | 287,361 | +15.4% | 0.02% | -15.0% |
| Q4 2015 | $9,299,000 | +154.0% | 249,032 | +158.2% | 0.02% | +122.2% |
| Q3 2015 | $3,661,000 | +142.9% | 96,432 | +81.8% | 0.01% | +125.0% |
| Q1 2014 | $1,507,000 | – | 53,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,752,000 | $58,919,000 | 16.72% |
| Antipodean Advisors LLC | 467,223 | $15,713,000 | 9.50% |
| BRIDGER MANAGEMENT, LLC | 2,412,501 | $81,132,000 | 5.24% |
| Signpost Capital Advisors, LP | 219,998 | $7,399,000 | 3.90% |
| Camber Capital Management LP | 2,000,000 | $67,260,000 | 3.25% |
| Partner Investment Management, L.P. | 50,808 | $1,709,000 | 2.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 368,392 | $12,389,000 | 2.77% |
| PFM Health Sciences, LP | 2,618,754 | $88,069,000 | 2.66% |
| IMA Wealth, Inc. | 99,569 | $3,300,000 | 2.07% |
| First Light Asset Management, LLC | 125,889 | $4,234,000 | 1.96% |